33442 Effectiveness in real world practice after 4 weeks of Risankizumab treatment for patients with moderate-to-severe psoriasis: 15-patient cohort.
Autor: | Navarro-Guillamon, Pedro J., Carmona-Olveira, Ana, Herrera-Acosta, Enrique |
---|---|
Zdroj: | In Journal of the American Academy of Dermatology September 2022 87(3) Supplement:AB49-AB49 |
Databáze: | ScienceDirect |
Externí odkaz: |